Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Increase in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 1,190,000 shares, a growth of 201.5% from the December 15th total of 394,700 shares. Based on an average daily trading volume, of 3,000,000 shares, the short-interest ratio is presently 0.4 days.

Aethlon Medical Stock Performance

Aethlon Medical stock opened at $0.69 on Thursday. The firm has a market cap of $9.60 million, a price-to-earnings ratio of -0.24 and a beta of 1.61. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.10. The firm’s 50 day moving average price is $0.51 and its two-hundred day moving average price is $0.44.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. StockNews.com started coverage on Aethlon Medical in a research note on Saturday, January 11th. They set a “sell” rating for the company. HC Wainwright restated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.